Why anti-TNF drugs don't work for some kids with Crohn's disease
A study by Michigan Medicine researchers has investigated possible genetic factors for drug efficacy for children with ...
MedPage Today11h
Major Heart Risks Similar With Two IBD Drugs in Older Adults
For older adults with inflammatory bowel disease (IBD), there was no significant difference in the risk of major ...
Healio17h
‘Lack of patient activation’ in pediatric IBD may be poor health literacy in disguise
Patient activation, earned trust and health literacy at patient, provider and health system levels are critical to overcoming ...
Science Daily1d
Crohn's Disease News
June 10, 2024 — Scientists have grown 'mini-guts' in the lab to help understand Crohn's disease, showing that 'switches' that modify DNA in gut cells play an ... Major Cause of Inflammatory ...
MedPage Today1d
JAK Inhibitors Remain a Viable Option for Older Adults With IBD
SAN FRANCISCO -- Janus kinase (JAK) inhibitors appeared to be a safe, effective option for treating inflammatory bowel ...
Rolling Out6d
Crohn’s disease and the symptoms no one talks about
Crohn’s disease isn’t just about digestion. From joint pain to vision issues, its hidden symptoms affect the body in unexpected ways.
EurekAlert!5d
Crohn's & Colitis Congress® spotlights key IBD research findings
The Crohn’s & Colitis Foundation and the American Gastroenterological Association (AGA) are excited to host the annual Crohn’s & Colitis Congress®, taking place Feb. 6-8, in San Francisco, CA. This ...
Pharmabiz1d
Eli Lilly presents positive results from VIVID-2 open-label extension study of Omvoh to treat Crohn's disease at Crohn's and Colitis Congress
Eli Lilly presents positive results from VIVID-2 open-label extension study of Omvoh to treat Crohn's disease at Crohn's and Colitis Congress: Indianapolis Monday, February 10, 20 ...